Data as of Mar 07
| -1.93 / -1.55%|
The 22 analysts offering 12-month price forecasts for Amgen Inc have a median target of 129.50, with a high estimate of 150.00 and a low estimate of 115.00. The median estimate represents a +5.92% increase from the last price of 122.26.
The current consensus among 28 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.